685 related articles for article (PubMed ID: 10078501)
1. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.
Robinson D; Woerner MG; Alvir JM; Bilder R; Goldman R; Geisler S; Koreen A; Sheitman B; Chakos M; Mayerhoff D; Lieberman JA
Arch Gen Psychiatry; 1999 Mar; 56(3):241-7. PubMed ID: 10078501
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic specificity of poor premorbid adjustment: comparison of schizophrenia, schizoaffective disorder, and mood disorder with psychotic features.
Tarbox SI; Brown LH; Haas GL
Schizophr Res; 2012 Oct; 141(1):91-7. PubMed ID: 22858353
[TBL] [Abstract][Full Text] [Related]
3. Cannabis Use and Symptomatic Relapse in First Episode Schizophrenia: Trigger or Consequence? Data From the OPTIMISE Study.
Levi L; Bar-Haim M; Winter-van Rossum I; Davidson M; Leucht S; Fleischhacker WW; Park J; Davis JM; Kahn RS; Weiser M
Schizophr Bull; 2023 Jul; 49(4):903-913. PubMed ID: 36999551
[TBL] [Abstract][Full Text] [Related]
4. Outcome of first-episode schizophrenia in India: longitudinal study of effect of insight and psychopathology.
Saravanan B; Jacob KS; Johnson S; Prince M; Bhugra D; David AS
Br J Psychiatry; 2010 Jun; 196(6):454-9. PubMed ID: 20513855
[TBL] [Abstract][Full Text] [Related]
5. A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohort.
Slot MIE; van Hell HH; Rossum IW; Dazzan P; Maat A; de Haan L; Crespo-Facorro B; Glenthøj B; Lawrie SM; McDonald C; Gruber O; van Amelsvoort T; Arango C; Kircher T; Nelson B; Galderisi S; Weiser M; Sachs G; Maatz A; Bressan RA; Kwon JS; Mizrahi R; ; McGuire P; Kahn RS
Schizophr Res; 2024 Apr; 266():237-248. PubMed ID: 38431986
[TBL] [Abstract][Full Text] [Related]
6. The contribution of first-episode illness characteristics and cumulative antipsychotic usage to progressive structural brain changes over a long-term follow-up in schizophrenia.
Konttajärvi T; Haapea M; Huhtaniska S; Björnholm L; Miettunen J; Isohanni M; Penttilä M; Murray GK; Koponen H; Vernon AC; Jääskeläinen E; Lieslehto J
Psychiatry Res Neuroimaging; 2024 Apr; 339():111790. PubMed ID: 38354478
[TBL] [Abstract][Full Text] [Related]
7. Acceptability of Texting 4 Relapse Prevention, Text Messaging-Based Relapse Prevention Program for People With Schizophrenia and Schizoaffective Disorder.
Ybarra ML; Rodriguez KM; Fehmie DA; Mojtabai R; Cullen B
J Nerv Ment Dis; 2022 Feb; 210(2):123-128. PubMed ID: 34570061
[TBL] [Abstract][Full Text] [Related]
8. Speech markers to predict and prevent recurrent episodes of psychosis: A narrative overview and emerging opportunities.
Zaher F; Diallo M; Achim AM; Joober R; Roy MA; Demers MF; Subramanian P; Lavigne KM; Lepage M; Gonzalez D; Zeljkovic I; Davis K; Mackinley M; Sabesan P; Lal S; Voppel A; Palaniyappan L
Schizophr Res; 2024 Apr; 266():205-215. PubMed ID: 38428118
[TBL] [Abstract][Full Text] [Related]
9. "Truman syndrome" induced by online education: A case report in adolescent-Onset psychosis.
Yildirim Budak B; Yazici Karabulut I
Clin Child Psychol Psychiatry; 2024 Apr; 29(2):540-549. PubMed ID: 37850453
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic maintenance treatment in schizophrenia and the importance of preventing relapse.
Emsley R
World Psychiatry; 2018 Jun; 17(2):168-169. PubMed ID: 29856555
[No Abstract] [Full Text] [Related]
11. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis.
Leucht S; Tardy M; Komossa K; Heres S; Kissling W; Salanti G; Davis JM
Lancet; 2012 Jun; 379(9831):2063-71. PubMed ID: 22560607
[TBL] [Abstract][Full Text] [Related]
12. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.
Tiihonen J; Haukka J; Taylor M; Haddad PM; Patel MX; Korhonen P
Am J Psychiatry; 2011 Jun; 168(6):603-9. PubMed ID: 21362741
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.
Lacro JP; Dunn LB; Dolder CR; Leckband SG; Jeste DV
J Clin Psychiatry; 2002 Oct; 63(10):892-909. PubMed ID: 12416599
[TBL] [Abstract][Full Text] [Related]
14. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.
Robinson DG; Woerner MG; Alvir JM; Geisler S; Koreen A; Sheitman B; Chakos M; Mayerhoff D; Bilder R; Goldman R; Lieberman JA
Am J Psychiatry; 1999 Apr; 156(4):544-9. PubMed ID: 10200732
[TBL] [Abstract][Full Text] [Related]
15. Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies.
Kishimoto T; Nitta M; Borenstein M; Kane JM; Correll CU
J Clin Psychiatry; 2013 Oct; 74(10):957-65. PubMed ID: 24229745
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
Lieberman JA; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Keefe RS; Davis SM; Davis CE; Lebowitz BD; Severe J; Hsiao JK;
N Engl J Med; 2005 Sep; 353(12):1209-23. PubMed ID: 16172203
[TBL] [Abstract][Full Text] [Related]
17. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort.
Wiersma D; Nienhuis FJ; Slooff CJ; Giel R
Schizophr Bull; 1998; 24(1):75-85. PubMed ID: 9502547
[TBL] [Abstract][Full Text] [Related]
18. Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials.
Kishimoto T; Robenzadeh A; Leucht C; Leucht S; Watanabe K; Mimura M; Borenstein M; Kane JM; Correll CU
Schizophr Bull; 2014 Jan; 40(1):192-213. PubMed ID: 23256986
[TBL] [Abstract][Full Text] [Related]
19. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia.
Weiden PJ; Kozma C; Grogg A; Locklear J
Psychiatr Serv; 2004 Aug; 55(8):886-91. PubMed ID: 15292538
[TBL] [Abstract][Full Text] [Related]
20. Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study.
Caseiro O; Pérez-Iglesias R; Mata I; Martínez-Garcia O; Pelayo-Terán JM; Tabares-Seisdedos R; Ortiz-García de la Foz V; Vázquez-Barquero JL; Crespo-Facorro B
J Psychiatr Res; 2012 Aug; 46(8):1099-105. PubMed ID: 22721546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
